{"id":"W4401876795","doi":"10.1016/s2152-2650(24)00983-2","title":"Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Bortezomib (BORT) or Carfilzomib (CFZ) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Results From the CC-92480-MM-002 Trial","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Lenalidomide; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001080289,0.0009647374,0.001507622,0.0002504557,0.0001889422,0.0009146542,0.0006444566,0.0008131322,0.003335285],"category_scores_gemma":[0.0008979637,0.0003000508,0.001291287,0.0004469114,0.0004969557,0.0007615417,0.0003653291,0.002688088,0.0006722849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007397647,"about_ca_system_score_gemma":0.0006335827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001416175,"about_ca_topic_score_gemma":0.004028009,"domain_scores_codex":[0.9996644,0.0001731999,0.00001519394,0.00005416778,0.00002797601,0.00006509028],"domain_scores_gemma":[0.9996467,0.00007026854,0.00008111542,0.00002550948,0.00001443712,0.0001619558],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8437151,0.00505692,0.006688072,0.001299692,0.003714028,0.0001402735,0.0001349525,0.001979452,0.01052429,0.0004600787,0.007349531,0.1189376],"study_design_scores_gemma":[0.841214,0.1077126,0.0346453,0.0001718022,0.002802402,0.0003241134,0.0001220206,0.00123268,0.001513643,0.0006470298,0.00956441,0.00004995667],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755687,0.01684519,0.000275338,0.00146708,0.0002819296,0.0004311082,0.001685381,0.0001101513,0.003335016],"genre_scores_gemma":[0.9849517,0.006728191,0.0006123693,0.001256171,0.0002623646,0.0004098899,0.002948425,0.00002826959,0.002802727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003335285,"threshold_uncertainty_score":0.01115769,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04655856962218402,"score_gpt":0.3310465867050094,"score_spread":0.2844880170828253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}